Cardurion Pharmaceuticals Secures $260M in Series B Funding

Burlington, MA, July 17, 2024 (Finance Yahoo)  --  Cardurion Pharmaceuticals has raised a Series B Financing round of $260 million. The funding will expand the indications being considered for CRD-750 and CRD-4730 and support late stage trials.  These candidates target heart failure and catecholaminergic polymorphic ventricular tachycardia, respectively.

Read full article here.